Contrary to the initial expectations that IRE1 signaling may protect against AD, genetic ablation of the RNAse domain of IRE1 in the nervous system significantly reduced APP expression and amyloid deposition, Aβ oligomer content and astrocyte activation. Here, APP is linked to Alzheimer disease.